242 related articles for article (PubMed ID: 25596085)
41. Protein expression of hypoxia-inducible factor-1 alpha and hepatocellular carcinoma: a systematic review with meta-analysis.
Cao S; Yang S; Wu C; Wang Y; Jiang J; Lu Z
Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):598-603. PubMed ID: 24835771
[TBL] [Abstract][Full Text] [Related]
42. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861
[TBL] [Abstract][Full Text] [Related]
43. Decreased expression of Beclin-1 in patients with hepatocellular carcinoma.
Sun H; Yu J; Wen Z; Wang M; Chen W
J BUON; 2019; 24(2):634-641. PubMed ID: 31128017
[TBL] [Abstract][Full Text] [Related]
44. Association of hypoxia-inducible factor 1α expression with susceptibility to hepatitis B virus-related hepatocellular carcinoma: A meta-analysis.
Wang L; Peng JL
Int J Biol Markers; 2023 Dec; 38(3-4):149-158. PubMed ID: 37787154
[TBL] [Abstract][Full Text] [Related]
45. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
[TBL] [Abstract][Full Text] [Related]
46. Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma.
Wu DH; Jia CC; Chen J; Lin ZX; Ruan DY; Li X; Lin Q; Min-Dong ; Ma XK; Wan XB; Cheng N; Chen ZH; Xing YF; Wu XY; Wen JY
Tumour Biol; 2014 Dec; 35(12):12225-33. PubMed ID: 25256671
[TBL] [Abstract][Full Text] [Related]
47. 14-3-3ζ promotes hepatocellular carcinoma venous metastasis by modulating hypoxia-inducible factor-1α.
Tang Y; Liu S; Li N; Guo W; Shi J; Yu H; Zhang L; Wang K; Liu S; Cheng S
Oncotarget; 2016 Mar; 7(13):15854-67. PubMed ID: 26910835
[TBL] [Abstract][Full Text] [Related]
48. The role of hypoxia inducible factor-1 in hepatocellular carcinoma.
Luo D; Wang Z; Wu J; Jiang C; Wu J
Biomed Res Int; 2014; 2014():409272. PubMed ID: 25101278
[TBL] [Abstract][Full Text] [Related]
49. High Beclin 1 expression defines a poor prognosis in endometrial adenocarcinomas.
Giatromanolaki A; Koukourakis MI; Koutsopoulos A; Chloropoulou P; Liberis V; Sivridis E
Gynecol Oncol; 2011 Oct; 123(1):147-51. PubMed ID: 21741077
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis B virus X protein and hypoxia‑inducible factor-1α stimulate Notch gene expression in liver cancer cells.
Yang SL; Ren QG; Zhang T; Pan X; Wen L; Hu JL; Yu C; He QJ
Oncol Rep; 2017 Jan; 37(1):348-356. PubMed ID: 27840976
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
Chang RM; Xu JF; Fang F; Yang H; Yang LY
Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
[TBL] [Abstract][Full Text] [Related]
52. Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.
Lin D; Wu J
World J Gastroenterol; 2015 Nov; 21(42):12171-8. PubMed ID: 26576101
[TBL] [Abstract][Full Text] [Related]
53. Targeting
Zhao Q; Zhang L; He Q; Chang H; Wang Z; Cao H; Zhou Y; Pan R; Chen Y
J Zhejiang Univ Sci B; 2023 Jan; 24(1):50-63. PubMed ID: 36632750
[TBL] [Abstract][Full Text] [Related]
54. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
Hamaguchi T; Iizuka N; Tsunedomi R; Hamamoto Y; Miyamoto T; Iida M; Tokuhisa Y; Sakamoto K; Takashima M; Tamesa T; Oka M
Int J Oncol; 2008 Oct; 33(4):725-31. PubMed ID: 18813785
[TBL] [Abstract][Full Text] [Related]
55. Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma.
Zhang M; Zhang W; Wu Z; Liu S; Sun L; Zhong Y; Zhang X; Kong X; Qian P; Zhang H; Lobie PE; Zhu T
Oncotarget; 2016 Jan; 7(3):3267-82. PubMed ID: 26675549
[TBL] [Abstract][Full Text] [Related]
56. Expression of BNIP3 and its correlations to hypoxia-induced autophagy and clinicopathological features in salivary adenoid cystic carcinoma.
Chen Z; Wu H; Huang S; Li W; Zhang S; Zheng P; Zhou X; Liu W; Zhang D
Cancer Biomark; 2015; 15(4):467-75. PubMed ID: 25769455
[TBL] [Abstract][Full Text] [Related]
57. PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1α expression and protein stability.
Liu Y; Zhang JB; Qin Y; Wang W; Wei L; Teng Y; Guo L; Zhang B; Lin Z; Liu J; Ren ZG; Ye QH; Xie Y
Hepatology; 2013 Aug; 58(2):692-705. PubMed ID: 23505027
[TBL] [Abstract][Full Text] [Related]
58. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma.
Ding ZB; Shi YH; Zhou J; Qiu SJ; Xu Y; Dai Z; Shi GM; Wang XY; Ke AW; Wu B; Fan J
Cancer Res; 2008 Nov; 68(22):9167-75. PubMed ID: 19010888
[TBL] [Abstract][Full Text] [Related]
59. Hypoxia-induced autophagy in triple negative breast cancer: association with prognostic variables, patients' survival and response to neoadjuvant chemotherapy.
El-Guindy DM; Ibrahim FM; Ali DA; El-Horany HE; Sabry NM; Elkholy RA; Mansour W; Helal DS
Virchows Arch; 2023 May; 482(5):823-837. PubMed ID: 36939902
[TBL] [Abstract][Full Text] [Related]
60. Role of hypoxia-inducible transcription factor 1alpha for progression and chemosensitivity of murine hepatocellular carcinoma.
Daskalow K; Rohwer N; Raskopf E; Dupuy E; Kühl A; Loddenkemper C; Wiedenmann B; Schmitz V; Cramer T
J Mol Med (Berl); 2010 Aug; 88(8):817-27. PubMed ID: 20383692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]